These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37141836)

  • 1. Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis.
    Tzogiou C; Wieser S; Eichler K; Carlander M; Djalali S; Rosemann T; Brändle M
    J Diabetes Complications; 2023 Jun; 37(6):108476. PubMed ID: 37141836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
    Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
    J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland.
    Brändle M; Azoulay M; Greiner RA
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):217-30. PubMed ID: 21329624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals.
    Yue X; Wu J; Ruan Z; Wolden ML; Li L; Lin Y
    Value Health Reg Issues; 2020 May; 21():17-21. PubMed ID: 31634792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of severe hypoglycemia in type 1 diabetes.
    Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
    Curr Med Res Opin; 2018 Jan; 34(1):171-177. PubMed ID: 29019269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of hypoglycaemia severity with clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin.
    Meneghini LF; Lee LK; Gupta S; Preblick R
    Diabetes Obes Metab; 2018 May; 20(5):1156-1165. PubMed ID: 29316141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
    Halimi S
    Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic impact of hypoglycemia on healthcare in Spain.
    Brito-Sanfiel M; Diago-Cabezudo J; Calderon A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):649-60. PubMed ID: 21155698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.
    Hoskins N; Tikkanen CK; Pedersen-Bjergaard U
    J Med Econ; 2017 Apr; 20(4):363-370. PubMed ID: 27926814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.
    Brändle M; Azoulay M; Greiner RA
    Int J Clin Pharmacol Ther; 2007 Apr; 45(4):203-20. PubMed ID: 17474539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.
    Leese GP; Wang J; Broomhall J; Kelly P; Marsden A; Morrison W; Frier BM; Morris AD;
    Diabetes Care; 2003 Apr; 26(4):1176-80. PubMed ID: 12663593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
    Giménez M; Elías I; Álvarez M; Quirós C; Conget I
    Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study.
    Emral R; Tetiker T; Sahin I; Sari R; Kaya A; Yetkin İ; Cil SU; Tütüncü NB;
    BMC Endocr Disord; 2018 Feb; 18(1):9. PubMed ID: 29433560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence rate and risk factors for hypoglycemia among individuals with type 1 diabetes or type 2 diabetes in China receiving insulin treatment.
    Chen S; Lu J; Peng D; Liu F; Lu W; Zhu W; Bao Y; Zhou J; Jia W
    Diabetes Res Clin Pract; 2023 Dec; 206():110987. PubMed ID: 37925076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
    Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
    Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.
    Shi L; Fonseca V; Childs B
    J Diabetes Complications; 2021 Jun; 35(6):107916. PubMed ID: 33836965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic effect of hypoglycemia in a health plan.
    Heaton A; Martin S; Brelje T
    Manag Care Interface; 2003 Jul; 16(7):23-7. PubMed ID: 12908214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.